SCHEMBL24545233

SCHEMBL24545233

Clc1ccc2c(c1)oc1ccc3nc(-c4ccccc4)oc3c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.59
CASP3 P42574 3/20 0.59
SENP7 Q9BQF6 3/20 0.59
SENP6 Q9GZR1 3/20 0.59
AHR P35869 3/20 0.49
KDM4E B2RXH2 6/20 0.44
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HPGD P15428 4/20 0.44
ALDH1A1 P00352 4/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
LMNA P02545 1/20 0.44
DHODH Q02127 1/20 0.43
SENP8 Q96LD8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24546994 0.91 SMN1; SMN2 (0.61) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL24546679 0.84 DHODH (0.46) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24546693 0.84 DHODH (0.46) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL26450602 0.84 ESR1 (0.50) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL31364269 0.83 SMN1; SMN2 (0.54) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL18544701 0.83 SMN1; SMN2 (0.54) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL27383240 0.82 SMN1; SMN2 (0.52) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL30201111 0.81 SMN1; SMN2 (0.55) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL25550019 0.81 SMN1; SMN2 (0.55) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL18814306 0.81 SMN1; SMN2 (0.55) SMN1; SMN2CASP3SENP7SENP6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-11-09 US disclosed
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-11-09 US disclosed
EP-4254527-A1 ORGANIC LIGHT EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-10-04 EP disclosed
WO-2022131757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME DRD1, OPRD1, NR1D1 SMN1; SMN2 1411/4885CASP3 3141/4885SENP7 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.